Aspire Biopharma Holdings, Inc. Share Price
ASBPAspire Biopharma Holdings, Inc. Stock Performance
Open $5.74 | Prev. Close $5.82 | Circuit Range N/A |
Day Range $5.74 - $5.74 | Year Range $0.05 - $7.04 | Volume 143 |
Average Traded $5.74 |
Aspire Biopharma Holdings, Inc. Share Price Chart
About Aspire Biopharma Holdings, Inc.
Aspire Biopharma Holdings, Inc., an early-stage biopharmaceutical company, develops and markets disruptive technology for novel sublingual delivery mechanisms in the United States. It offers Instaprin, a sublingual aspirin product that is a soluble, PH neutral, and fast acting aspirin, which addresses cardiology emergencies and pain management. The company is also developing formulations for sublingually administered products, including a melatonin sleep-aid product; vitamins D, E, and K; testosterone; and semaglutide product. In addition, it is developing formulations for anti-nausea products, anti-psychotic products, ED drugs, seizure medication, and other classes of drugs through sublingual administration; and caffeine products, such as a formula for a single dose sublingual pre-workout supplement. The company was founded in 2021 and is headquartered in Estero, Florida.
Aspire Biopharma Holdings, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
09-Jun-26 | $6.47 | $5.99 | +2.05% |
08-Jun-26 | $5.90 | $5.87 | +4.36% |
05-Jun-26 | $5.72 | $5.62 | -7.72% |
04-Jun-26 | $5.91 | $6.09 | +3.31% |
03-Jun-26 | $5.89 | $5.89 | +0.77% |
01-Jun-26 | $5.39 | $5.85 | +8.13% |
29-May-26 | $5.43 | $5.41 | -1.64% |